Charissa Elliott
Family · West Burlington, IANPI 1356760011
Payments from drug & device makers
Across 72 payments — averaging $24.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$317
- AbbVie$206
- Otsuka America Pharmaceutical, Inc.$203
- Biohaven Pharmaceutical Holding Company Ltd.$153
- Novo Nordisk$149
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$137
- plus $572 from 17 others
What the payments were for
- Food & beverage$1,738100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 9 | $317 |
| AbbVie | 12 | $206 |
| Otsuka America Pharmaceutical, Inc. | 3 | $203 |
| Biohaven Pharmaceutical Holding Company Ltd. | 6 | $153 |
| Novo Nordisk | 4 | $149 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 9 | $137 |
| Bayer | 3 | $126 |
| Pfizer | 4 | $61 |
| Axsome Therapeutics, Inc. | 3 | $51 |
| Johnson & Johnson | 3 | $46 |
| Alkermes, Inc. | 2 | $36 |
| Neurocrine Biosciences, Inc. | 2 | $35 |
| Exact Sciences | 2 | $32 |
| Medtronic | 1 | $31 |
| Actelion Pharmaceuticals US, Inc. | 1 | $23 |
| Mylan Specialty L.p. | 1 | $22 |
| Dexcom, Inc. | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
| Lundbeck LLC | 1 | $16 |
| Astellas Pharma US Inc | 1 | $15 |
| Lilly USA, LLC | 1 | $15 |
| Corium, LLC | 1 | $14 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BREZTRI$125
- NURTEC ODT$125
How this compares
$1,738 in reported general payments places this provider in the 85th percentile of 1,268 family providers in Iowa.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 30 | $36,947 |
| OzempicSemaglutide | 22 | $27,468 |
| TrulicityDulaglutide | 11 | $16,338 |
| MounjaroTirzepatide | 14 | $14,833 |
| JardianceEmpagliflozin | 13 | $13,487 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 12 | $12,997 |
| SymbicortBudesonide/Formoterol Fumarate | 13 | $5,036 |
| Ventolin HfaAlbuterol Sulfate | 14 | $1,689 |
| Hydroxyzine Hcl | 41 | $1,199 |
| Nano 2nd Gen Pen NeedlePen Needle, Diabetic | 11 | $1,146 |
| Omeprazole | 60 | $1,023 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 27 | $850 |
| Gabapentin | 73 | $839 |
| Levothyroxine Sodium | 83 | $567 |
| Fluticasone Propionate | 52 | $530 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $317 | $54,98055 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $15 | $31,17125 claims |
| Novo NordiskOzempic | $149 | $27,46822 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,268 family providers in Iowa.
Other family in West Burlington
- Nicole FerrillWest Burlington$5K
- Stefanie GaticaAnkeny$354K
- Aubrey MolgaardAmes$238K
- Joan KittenFort Dodge$85K
- Megan FergusonPella$82K
- Rodney ClarkDes Moines$63K
- Jennifer CondonFort Dodge$31K
- Karen HunkeAmes$20K
- Tonia AckermanWest Des Moines$17K
- Chi-Ying SageWaterloo$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.